Milan, 5 July 2022 – De Berti Jacchia assisted EA Pharma, one of the leading French pharmaceutical group active in the oligotherapy, sports nutrition and food supplement industries, in the acquisition of Stardea Srl, a leading Italian player active in the distribution and marketing of nutraceutical products, including food supplements, medical devices and dermo-cosmetics, belonging to the Cooper Consumer Health Group.
The goal of the transaction was that of strengthening the position of EA PHARMA in the direct distribution of its products in Italy by combining activities and resources, as well as by exploiting synergies already existing in this domain of business.
De Berti Jacchia team – which assisted EA Pharma on all legal aspects, structuring and coordinating the overall transaction – was headed by the Dispute and Employment partner Michelangelo Cicogna, together with the M&A partner Claudio Corba Colombo, assisted by the employment partner Andrea Sonino and the senior associates Benedetta Mazzotti and Isabella Basilico.
EA Pharma advisor for French law-related issues was G | C | A – Cabinet d’Avocats with a team headed by Alexandre Gaudin, assisted by the associate Pauline Céard.
The tax and financial aspects were covered by PWC, with a team composed by Martin Naquet-Radiguet (PWC France) and Nicola Broggi and Pietro Bertolotti (PWC Italy).
The seller, Versailles BV, was assisted on the M&A side by Oaklins (Banco BPM group) with Antoine Lemaire, Paolo Russo, Loris Gabrielian, Charlotte Delphis and Nicholas Bolzoni, and, on the legal and tax side, by Studio Associato Furlotti with a team headed by Gigetto Furlotti (name partner), Fabrizio Pizzola (founder partner), Paolo Delieti (senior partner) together with Filippo Mattioli (associate).